RT-qPCR data confirmed that ANGPTL4 was also significantly upregulated in RADH87 primary GBM cells (by 1.8-fold and 3-fold at 24 h and 72 h, respectively) as well as in patient tumors (by 2.5-fold) treated by 1 μM G-1 for 72 h (Figure 3A,B). The gene discussed is ANGPTL4; the disease is glioblastoma.